AI Verdict
NTLA has stronger fundamentals based on our AI analysis.
NTLA vs NTIP Fundamental Comparison
| Metric | NTLA | NTIP |
|---|---|---|
| Revenue | $67.7M | $150,000.0 |
| Net Income | $-412.7M | $-2.4M |
| Net Margin | -609.9% | -1,613.3% |
| ROE | -61.5% | -6.1% |
| ROA | -49.0% | -6.0% |
| Current Ratio | 5.08x | 48.19x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-3.81 | $-0.11 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NTLA vs NTIP: Frequently Asked Questions
Is NTLA or NTIP a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NTLA has stronger fundamentals. NTLA is rated SELL (92% confidence) while NTIP is rated STRONG SELL (92% confidence). This is not investment advice.
How does NTLA compare to NTIP fundamentally?
Intellia Therapeutics, Inc. has ROE of -61.5% vs NETWORK-1 TECHNOLOGIES, INC.'s -6.1%. Net margins are -609.9% vs -1,613.3% respectively.
Which stock pays higher dividends, NTLA or NTIP?
NTLA has a dividend yield of N/A or no dividend while NTIP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NTLA or NTIP for long term?
For long-term investing, consider that NTLA has SELL rating with 92% confidence, while NTIP has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NTLA vs NTIP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NTLA vs NTIP, the AI consensus favors NTLA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.